A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03350542

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03350542
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Latvia, New Zealand, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03350542. Allocation not applicable; no masking; primary purpose treatment. Start 2018-04-12 (actual); primary completion 2020-01-16 (actual). Results posted on 2021-02-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)
Acronym
EVOLVE48
Intervention (Device)
SYNERGY 48 mm
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct03350542
Content hash
22e1a0a913f707497214a35663d0932a91a4d8c0c5c7b364894eea51a88e7f35